NCT03892499View on ClinicalTrials.gov

A Trial to Evaluate the Effect of Itraconazole (ITZ), a CYP3A4 Inhibitor, on the Pharmacokinetics of the Soluble Guanylate Cyclase Stimulator, Olinciguat (IW-1701), in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

May 3, 2019

Primary Completion Date

June 23, 2019

Study Completion Date

July 3, 2019

Conditions
Healthy
Interventions
DRUG

Olinciguat

Oral Tablet

DRUG

Itraconazole

Oral Capsule

Trial Locations (1)

78744

PPD, Austin

Sponsors
All Listed Sponsors
lead

Cyclerion Therapeutics

INDUSTRY

NCT03892499 - A Trial to Evaluate the Effect of Itraconazole (ITZ), a CYP3A4 Inhibitor, on the Pharmacokinetics of the Soluble Guanylate Cyclase Stimulator, Olinciguat (IW-1701), in Healthy Volunteers | Biotech Hunter | Biotech Hunter